M. Ruiz-Ponce

562 total citations · 1 hit paper
11 papers, 371 citations indexed

About

M. Ruiz-Ponce is a scholar working on Rheumatology, Surgery and Epidemiology. According to data from OpenAlex, M. Ruiz-Ponce has authored 11 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 3 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in M. Ruiz-Ponce's work include Spondyloarthritis Studies and Treatments (4 papers), Eosinophilic Esophagitis (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). M. Ruiz-Ponce is often cited by papers focused on Spondyloarthritis Studies and Treatments (4 papers), Eosinophilic Esophagitis (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). M. Ruiz-Ponce collaborates with scholars based in Spain, Italy and Ireland. M. Ruiz-Ponce's co-authors include Emilio J. Laserna‐Mendieta, Alfredo J. Lucendo, Ángel Arias, Laura Arias‐González, Pilar Navarro, I. Arias de la Rosa, C. López-Pedrera, Eduardo Collantes‐Estévez, Jésus Barrio and Teresa Ramón y Cajal Asensio and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Alimentary Pharmacology & Therapeutics.

In The Last Decade

M. Ruiz-Ponce

10 papers receiving 369 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies

2019 204 citations Pilar Navarro, Ángel Arias et al. Alimentary Pharmacology & Therapeutics profile →

Peers

Countries citing papers authored by M. Ruiz-Ponce

Since Specialization

Citations

This map shows the geographic impact of M. Ruiz-Ponce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ruiz-Ponce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ruiz-Ponce more than expected).

Fields of papers citing papers by M. Ruiz-Ponce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ruiz-Ponce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ruiz-Ponce. The network helps show where M. Ruiz-Ponce may publish in the future.

Co-authorship network of co-authors of M. Ruiz-Ponce

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ruiz-Ponce. A scholar is included among the top collaborators of M. Ruiz-Ponce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ruiz-Ponce. M. Ruiz-Ponce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Molecular insights into the relationship between sustained CRP elevation and endothelial dysfunction in axial spondyloarthritis 2025 ·RMD Open ·(unknown), I. Arias de la Rosa, (unknown), (unknown), Lourdes Ladehesa-Pineda, M. Ruiz-Ponce, (unknown), C. Pérez‐Sánchez, P. Segui, (unknown), J. Calvo-Gutiérrez, (unknown), D. Ruiz, (unknown), (unknown), C. López-Pedrera, (unknown), Eduardo Collantes‐Estévez, Clementina López‐Medina, Nuria Barbarroja	0
2	Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling 2024 ·Frontiers in Immunology ·(unknown), Alejandro Escudero‐Contreras, (unknown), C. Pérez‐Sánchez, M. Ruiz-Ponce, Julio M. Martínez‐Moreno, Eva Pérez‐Pampín, Antonio González, Chamaida Plasencia‐Rodríguez, Ana Martínez‐Feito, Alejandro Balsa, Clementina López‐Medina, Lourdes Ladehesa-Pineda, (unknown), R. Ortega Castro, J. Calvo-Gutiérrez, C. López-Pedrera, Eduardo Collantes‐Estévez, I. Arias de la Rosa, Nuria Barbarroja	6
3	Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses 2023 ·Biomedicine & Pharmacotherapy ·M. Ruiz-Ponce, (unknown), (unknown), C. Pérez‐Sánchez, (unknown), A. Barranco, Manuel D. Gahete, (unknown), Alfredo J. Lucendo, Pilar Navarro, C. López-Pedrera, Alejandro Escudero‐Contreras, Eduardo Collantes‐Estévez, Clementina López‐Medina, I. Arias de la Rosa, Nuria Barbarroja	6
4	Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets 2023 ·Frontiers in Immunology ·Nuria Barbarroja, (unknown), (unknown), C. Pérez‐Sánchez, M. Ruiz-Ponce, Clementina López‐Medina, Lourdes Ladehesa-Pineda, C. López-Pedrera, Alejandro Escudero‐Contreras, Eduardo Collantes‐Estévez, I. Arias de la Rosa	14
5	Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk 2022 ·Frontiers in Immunology ·Nuria Barbarroja, M. Ruiz-Ponce, (unknown), C. Pérez‐Sánchez, C. López-Pedrera, I. Arias de la Rosa, Eduardo Collantes‐Estévez	19
6	Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs 2021 ·Frontiers in Immunology ·I. Arias de la Rosa, Alejandro Escudero‐Contreras, M. Ruiz-Ponce, (unknown), C. Pérez‐Sánchez, (unknown), R. Ortega Castro, Juan Alcaide, Mora Murri, Pilar Font, J. Calvo-Gutiérrez, M. Luque-Tévar, (unknown), Rocío Guzmán‐Ruiz, Marı́a M. Malagón, Francisco J. Tinahones, Eduardo Collantes‐Estévez, C. López-Pedrera, Nuria Barbarroja	7
7	Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice 2020 ·Clinical Gastroenterology and Hepatology ·Emilio J. Laserna‐Mendieta, Sergio Casabona, Edoardo Savarino, Antonia Perelló, Isabel Pérez‐Martínez, Danila Guagnozzi, Jésus Barrio, (unknown), Teresa Ramón y Cajal Asensio, S. Riva, M. Ruiz-Ponce, Juan A. Rodríguez-Oballe, Cecílio Santander, Ángel Arias, Alfredo J. Lucendo	71
8	Esophageal perforation in eosinophilic esophagitis: A systematic review on clinical presentation, management and outcomes 2019 ·Digestive and Liver Disease ·Laura Arias‐González, (unknown), M. Ruiz-Ponce, Emilio J. Laserna‐Mendieta, Ángel Arias, Alfredo J. Lucendo	23
9	Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies breakdown → 2019 ·Alimentary Pharmacology & Therapeutics ·Pilar Navarro, Ángel Arias, Laura Arias‐González, Emilio J. Laserna‐Mendieta, M. Ruiz-Ponce, Alfredo J. Lucendo	204
10	Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits 2019 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Emilio J. Laserna‐Mendieta, (unknown), Laura Arias‐González, M. Ruiz-Ponce, Luís Menchén, César Sánchez, Luis A. López‐Fernández, Alfredo J. Lucendo	17
11	SAT0331 Inflammatory markers and adipokines related to cardiovascular risk and metabolic comorbidities in psoriatic arthritis. in vivo effects of apremilast 2018 ·Annals of the Rheumatic Diseases ·I. Arias de la Rosa, (unknown), C. Pérez‐Sánchez, M. C. Ábalos‐Aguilera, M. Ruiz-Ponce, Yolanda Jiménez, Alejandro Escudero‐Contreras, Eduardo Collantes‐Estévez, C. López-Pedrera, Nuria Barbarroja	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact